Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 2/20 | 0.37 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1505805 | 0.86 | PKM (0.57) | PKMPOLBMAPTELANETSHR | |
| SCHEMBL6635239 | 0.82 | ALDH1A1 (0.40) | PKMPOLBMAPTELANEALDH1A1 | |
| SCHEMBL13922302 | 0.81 | MMP2 (0.42) | PKMPOLBMAPTELANEF2 | |
| SCHEMBL6632013 | 0.80 | — | — | |
| SCHEMBL4530562 | 0.80 | RAB9A (0.35) | PKMPOLBMAPTELANEALDH1A1 | |
| SCHEMBL6635153 | 0.78 | NSD2 (0.39) | MAPTELANEKMT2ACA1CA2 | |
| SCHEMBL13922721 | 0.75 | MMP2 (0.38) | PKMPOLBMAPTELANEF2 | |
| SCHEMBL12833375 | 0.73 | KIF11 (0.39) | TP53KMT2AGAASMN1; SMN2 | |
| SCHEMBL1505815 | 0.73 | KIF11 (0.39) | TP53KMT2AGAASMN1; SMN2 | |
| SCHEMBL12833374 | 0.73 | KMT2A (0.43) | MAPTELANEF2CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697824-B2 | Cross-linkable bi-sulphonyl derivatives and their uses for preparing ion-exchanging membranes | HYDRO QUEBEC (CA) | 2014-04-15 | — | — | US | disclosed |
| EP-1286961-B1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2004-05-19 | — | — | EP | disclosed |
| EP-1286961-A1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M Innovative Properties Company (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6384167-B2 | MECHANICAL PROPERTIES ALONG WITH A DESIRABLE LEVEL OF IONIC CONDUCTIVITY; ION-EXCHANGE MEMBRANES | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | disclosed |
| US-20020007083-A1 | Sulfonated perfluorovinyl functional monomers | 3M INNOVATIVE PROPERTIES COMPANY | 2002-01-17 | — | — | US | disclosed |
| WO-2001094305-A1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| US-6268532-B1 | USED FOR PREPARING SULFONATED OR NON-SULFONATED BLOCK POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007083-A1 | Sulfonated perfluorovinyl functional monomers | AFF2, AFF1, FOS | PKM 3550/4885POLB 3080/4885MAPT 4365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.